Eliminating breast surgery for invasive breast cancer in exceptional responders to neoadjuvant systemic therapy: a multicentre, single-arm, phase 2 trial

Exceptional Responders Clinical Trials Group

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Eliminating breast surgery for invasive breast cancer in exceptional responders to neoadjuvant systemic therapy: a multicentre, single-arm, phase 2 trial'. Together they form a unique fingerprint.

Medicine & Life Sciences